{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T04:08:46Z","timestamp":1788754126723,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bjid.2025.104514","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T20:04:58Z","timestamp":1739995498000},"page":"104514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treatment costs of long-term invasive meningococcal disease sequelae: A literature review and Delphi study in Brazil"],"prefix":"10.1016","volume":"29","author":[{"given":"Noemia Teixeira de Siqueira","family":"Filha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Cortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2174-268X","authenticated-orcid":false,"given":"Meline","family":"Kron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maira Galdino da Rocha","family":"Pitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Zanghelini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruna","family":"de Veras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiane Almeida","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lessandra","family":"Michelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0957-3118","authenticated-orcid":false,"given":"Thatiana","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2025.104514_bib0001","doi-asserted-by":"crossref","first-page":"165","DOI":"10.14295\/vittalle.v32i1.9645","article-title":"Invasive meningococcal disease in Brazil: a literature review","volume":"32","author":"Silveira","year":"2020","journal-title":"Vittalle \u2013 Rev Ci\u00eancias Sa\u00fade"},{"key":"10.1016\/j.bjid.2025.104514_bib0002","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1080\/21645515.2019.1700710","article-title":"A critical analysis of serogroup B meningococcal disease burden in Brazil (2001\u20122015): implications for public health decisions","volume":"16","author":"Chicuto","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.bjid.2025.104514_bib0003","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijid.2019.01.009","article-title":"Epidemiological burden of meningococcal disease in Brazil: a systematic literature review and database analysis","volume":"80","author":"Presa","year":"2019","journal-title":"Int J Inf Dis"},{"key":"10.1016\/j.bjid.2025.104514_bib0004","doi-asserted-by":"crossref","first-page":"ofv167","DOI":"10.1093\/ofid\/ofv167","article-title":"Economic impact of meningococcal outbreaks in Brazil and Colombia","volume":"2","author":"Constenla","year":"2015","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.bjid.2025.104514_bib0005","first-page":"1458","article-title":"Meningococcal disease in S\u00e3o Paulo, Brazil, in the 20th century: epidemiological characteristics","volume":"21","author":"de Moraes","year":"2005","journal-title":"Cad Saude Publica"},{"key":"10.1016\/j.bjid.2025.104514_bib0006","unstructured":"Minist\u00e9rio de Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade e Ambiente. Secretaria de Aten\u00e7\u00e3o Especializada \u00e0 Sa\u00fade. Secretaria de Aten\u00e7\u00e3o Prim\u00e1ria \u00e0 Sa\u00fade. Nota t\u00e9cnica conjunta n\u00b0 46 2023. Available at: https:\/\/www.alagoas24horas.com.br\/wp-content\/uploads\/2023\/10\/Nota-Tecnica-Conjunta-no-462-023-SVSA-SAES-SAPS-MS.pdf. (Accessed December 10, 2023)."},{"key":"10.1016\/j.bjid.2025.104514_bib0007","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.vaccine.2020.11.067","article-title":"Meningococcal disease epidemiology in Brazil (2005\u20122018) and impact of MenC vaccination","volume":"39","author":"Aparecido Nunes","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2025.104514_bib0008","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1186\/s12889-022-13342-2","article-title":"Range of invasive meningococcal disease sequelae and health economic application - a systematic and clinical review","volume":"22","author":"Shen","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.bjid.2025.104514_bib0009","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40121-018-0213-2","article-title":"Systematic review of invasive meningococcal disease: sequelae and quality of life impact on patients and their caregivers","volume":"7","author":"Olbrich","year":"2018","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bjid.2025.104514_bib0010","doi-asserted-by":"crossref","unstructured":"Carpiuc K.T., Snedecor S.J., Roberts C.S., Fujii R.K., Eds.. Epidemiology and costs of meningococcal disease in Brazil: a survey of the literature (PIN 6, A80). Value in Health; 2013.","DOI":"10.1016\/j.jval.2013.03.365"},{"key":"10.1016\/j.bjid.2025.104514_bib0011","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1186\/s12913-021-07117-5","article-title":"Costs related to immunopreventable diseases: Brazil and its geographic areas (immunopreventable diseases\u2019 costs in Brazil)","volume":"21","author":"da Costa","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.bjid.2025.104514_bib0012","doi-asserted-by":"crossref","unstructured":"Salgado J.B., Silva D.O., Lorenzato F., Cintra O.A., Saturnino L.T., Eds. Direct costs associated to meningococcal disease and related sequelae in children - ana lysis based on the Brazilian public health system perspective (PIN 87, A422). Value in Health; 2016.","DOI":"10.1016\/j.jval.2016.09.438"},{"key":"10.1016\/j.bjid.2025.104514_bib0013","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/microorganisms9050900","article-title":"The impact and burden of neurological sequelae following bacterial meningitis: a narrative review","volume":"9","author":"Schiess","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.bjid.2025.104514_bib0014","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s40273-018-0679-5","article-title":"Costs of invasive meningococcal disease: a global systematic review","volume":"36","author":"Wang","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bjid.2025.104514_bib0015","unstructured":"PROSPERO Protocol: Social and economic costs of sequelae caused by meningococcal invasive disease. 2022. Available at: https:\/\/www.crd.york.ac.uk\/prospero\/display_record.php?RecordID=299697. (Accessed December 10, 2023)."},{"key":"10.1016\/j.bjid.2025.104514_bib0016","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jval.2021.10.008","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 explanation and elaboration: a report of the ISPOR CHEERS II Good Practices Task Force","volume":"25","author":"Husereau","year":"2022","journal-title":"Value Health"},{"key":"10.1016\/j.bjid.2025.104514_bib0017","unstructured":"International Monetary Fund (IMF). IMF Data 2021. Available at: https:\/\/www.imf.org\/en\/Data. (Accessed December 10, 2023)."},{"key":"10.1016\/j.bjid.2025.104514_bib0018","unstructured":"The Organisation for Economic Co-operation and Development (OECD). Purchasing power parities (PPP) 2016. Available at: https:\/\/data.oecd.org\/conversion\/purchasing-power-parities-ppp.htm. (Accessed December 10, 2023)."},{"key":"10.1016\/j.bjid.2025.104514_bib0019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fpubh.2020.00457","article-title":"Delphi technique in health sciences: a map","volume":"8","author":"Niederberger","year":"2020","journal-title":"Front Public Health"},{"key":"10.1016\/j.bjid.2025.104514_bib0020","unstructured":"Minist\u00e9rio da Sa\u00fade. SIGTAP \u2012 Sistema de Gerenciamento da Tabela de Procedimentos, Medicamentos e OPM do SUS. 2024. Available at: http:\/\/sigtap.datasus.gov.br\/tabela-unificada\/app\/sec\/inicio.jsp. (Accessed June 27, 2024)."},{"key":"10.1016\/j.bjid.2025.104514_bib0021","unstructured":"Minist\u00e9rio da Sa\u00fade. Contas do SUS na perspectiva da contabilidade internacional: Brasil, 2010-2014. 2018. Available at: https:\/\/bvsms.saude.gov.br\/bvs\/publicacoes\/contas_SUS_perspectiva_contabilidade_internacional_2010_2014.pdf. (Accessed June 27, 2024)."},{"key":"10.1016\/j.bjid.2025.104514_bib0022","unstructured":"Comiss\u00e3o Nacional de Incorpora\u00e7\u00e3o de Tecnologias no Sistema \u00danico de Sa\u00fade. Vacina da Fiocruz [ChAdOx-1 (Vacina COVID-19 recombinante)] e da Pfizer\/Wyeth [BNT162b2 (Vacina COVID-19)] para preven\u00e7\u00e3o da COVID-19. 2024. Available at: https:\/\/www.gov.br\/conitec\/pt-br\/midias\/relatorios\/2021\/20210630_relatorio_634_vacinas_covid-19_final.pdf\/view. (Accessed June 27, 2024)."},{"key":"10.1016\/j.bjid.2025.104514_bib0023","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.vhri.2022.01.009","article-title":"Cost utility of vaccination against COVID-19 in Brazil","volume":"31","author":"Fernandes","year":"2022","journal-title":"Value Health Reg Issues"},{"key":"10.1016\/j.bjid.2025.104514_bib0024","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1016\/j.ehrm.2011.08.001","article-title":"Costs of sequelae associated with invasive meningococcal disease: findings from a US managed care population","volume":"2","author":"Karve","year":"2011","journal-title":"Health Outcomes Res Med"},{"key":"10.1016\/j.bjid.2025.104514_bib0025","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s40121-021-00468-w","article-title":"Healthcare resource consumption and cost of invasive meningococcal disease in France: a study of the national health insurance database","volume":"10","author":"Weil-Olivier","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bjid.2025.104514_bib0026","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1016\/j.vaccine.2014.05.069","article-title":"The inpatient costs and hospital service use associated with invasive meningococcal disease in South Australian children","volume":"32","author":"Wang","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2025.104514_bib0027","doi-asserted-by":"crossref","first-page":"6885","DOI":"10.1016\/j.vaccine.2019.09.060","article-title":"Lifetime costs of invasive meningococcal disease: a Markov model approach","volume":"37","author":"Wang","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2025.104514_bib0028","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s40272-012-0006-0","article-title":"Counting the cost of meningococcal disease: scenarios of severe meningitis and septicemia","volume":"15","author":"Wright","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.bjid.2025.104514_bib0029","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1016\/j.vaccine.2014.07.019","article-title":"Costs of surviving meningococcal disease in Spain: evaluation for two cases of severe meningitis and septicaemia","volume":"32","author":"Darb\u00e0","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2025.104514_bib0030","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jiph.2015.10.016","article-title":"Lifetime cost of meningococcal disease in France: scenarios of severe meningitis and septicemia with purpura fulminans","volume":"9","author":"B\u00e9nard","year":"2016","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.bjid.2025.104514_bib0031","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.vaccine.2019.01.013","article-title":"The cost-of-illness for invasive meningococcal disease caused by serogroup B Neisseria meningitidis (MenB) in Germany","volume":"37","author":"Scholz","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.bjid.2025.104514_bib0032","doi-asserted-by":"crossref","DOI":"10.1590\/S0103-73312012000200013","article-title":"A import\u00e2ncia dos m\u00e9todos de custeio e valora\u00e7\u00e3o nas avalia\u00e7\u00f5es econ\u00f4micas em sa\u00fade: repercuss\u00f5es sobre os resultados de avalia\u00e7\u00e3o da vacina antimeningoc\u00f3cica C","volume":"22","author":"Itria","year":"2012","journal-title":"PHYSIS: Rev Saude Coletiva"},{"key":"10.1016\/j.bjid.2025.104514_bib0033","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/hec.776","article-title":"Catastrophe and impoverishment in paying for health care: with applications to Vietnam 1993-1998","volume":"12","author":"Wagstaff","year":"2003","journal-title":"Health Econ"},{"key":"10.1016\/j.bjid.2025.104514_bib0034","unstructured":"Centers for Disease Control and Prevention (CDC). Meningococcal disease in other countries 2023. Available at: https:\/\/www.cdc.gov\/meningococcal\/php\/global\/?CDC_AAref_Val=https:\/\/www.cdc.gov\/meningococcal\/global.html PLS?. (Accessed December 10, 2023)."}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867025000170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867025000170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T08:07:49Z","timestamp":1744445269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867025000170"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1413867025000170"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2025.104514","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment costs of long-term invasive meningococcal disease sequelae: A literature review and Delphi study in Brazil","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2025.104514","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"104514"}}